BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23346457)

  • 1. Omega-3 Fatty acids and vitamin d in cardiology.
    Güttler N; Zheleva K; Parahuleva M; Chasan R; Bilgin M; Neuhof C; Burgazli M; Niemann B; Erdogan A; Böning A
    Cardiol Res Pract; 2012; 2012():729670. PubMed ID: 23346457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: Relevance for cardiovascular outcomes.
    Colussi G; Catena C; Novello M; Bertin N; Sechi LA
    Nutr Metab Cardiovasc Dis; 2017 Mar; 27(3):191-200. PubMed ID: 27692558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of ω3 long-chain polyunsaturated fatty acids in reducing cardio-metabolic risk factors.
    Abeywardena MY; Patten GS
    Endocr Metab Immune Disord Drug Targets; 2011 Sep; 11(3):232-46. PubMed ID: 21831036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with n-3 polyunsaturated fatty acids overcomes the inverse association of vitamin D deficiency with inflammation in severely obese patients: a randomized controlled trial.
    Itariu BK; Zeyda M; Leitner L; Marculescu R; Stulnig TM
    PLoS One; 2013; 8(1):e54634. PubMed ID: 23372745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D and Omega-3 (Fatty Acid) Supplementation in Pregnancy for the Primary Prevention of Food Allergy in Children-Literature Review.
    Feketea G; Kostara M; Bumbacea RS; Vassilopoulou E; Tsabouri S
    Children (Basel); 2023 Feb; 10(3):. PubMed ID: 36980026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials.
    Casula M; Olmastroni E; Gazzotti M; Galimberti F; Zambon A; Catapano AL
    Pharmacol Res; 2020 Oct; 160():105060. PubMed ID: 32634581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supplementation with omega-3 fatty acids during gestation and lactation to a vitamin B12-deficient or -supplemented diet improves pregnancy outcome and metabolic variables in Wistar rats.
    Khaire A; Rathod R; Kemse N; Kale A; Joshi S
    Reprod Fertil Dev; 2015 Jan; 27(2):341-50. PubMed ID: 24355403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marine-Derived Omega-3 Polyunsaturated Fatty Acids and Heart Failure: Current Understanding for Basic to Clinical Relevance.
    Sakamoto A; Saotome M; Iguchi K; Maekawa Y
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D and cardiovascular disease will it live up to its hype?
    Lavie CJ; Lee JH; Milani RV
    J Am Coll Cardiol; 2011 Oct; 58(15):1547-56. PubMed ID: 21958881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of vitamin D and omega-3 fatty acids co-supplementation on inflammatory biomarkers, tumor marker CEA, and nutritional status in patients with colorectal cancer: a study protocol for a double blind randomized controlled trial.
    Haidari F; Abiri B; Iravani M; Razavi SM; Sarbakhsh P; Ahmadi-Angali K; Vafa M
    Trials; 2019 Dec; 20(1):682. PubMed ID: 31815661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega-3 fatty acid supplementation and cardiovascular disease.
    Jump DB; Depner CM; Tripathy S
    J Lipid Res; 2012 Dec; 53(12):2525-45. PubMed ID: 22904344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Omega-3 Polyunsaturated Fatty Acid Supplementation in Patients with Atrial Fibrillation.
    Kumar S; Qu S; Kassotis JT
    J Atr Fibrillation; 2012; 5(2):502. PubMed ID: 28496756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. n-3 fatty acids and revascularization procedures.
    Arnesen H
    Lipids; 2001; 36 Suppl():S103-6. PubMed ID: 11837981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D for the prevention of cardiovascular disease: Are we ready for that?
    Carvalho LS; Sposito AC
    Atherosclerosis; 2015 Aug; 241(2):729-40. PubMed ID: 26135478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Membrane lipids in schizophrenia and early phases of psychosis: Potential biomarkers and therapeutic targets?].
    Frajerman A; Kebir O; Chaumette B; Tessier C; Lamazière A; Nuss P; Krebs MO
    Encephale; 2020 Jun; 46(3):209-216. PubMed ID: 32151446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events.
    Mozaffarian D; Wu JH
    J Am Coll Cardiol; 2011 Nov; 58(20):2047-67. PubMed ID: 22051327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of Cardiovascular Events with Omega-3 Polyunsaturated Fatty Acids and the Mechanism Involved.
    Watanabe Y; Tatsuno I
    J Atheroscler Thromb; 2020 Mar; 27(3):183-198. PubMed ID: 31582621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enrichment of eggs with n-3 polyunsaturated fatty acids: effects of vitamin E supplementation.
    Grune T; Krämer K; Hoppe PP; Siems W
    Lipids; 2001 Aug; 36(8):833-8. PubMed ID: 11592735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega-3 fatty acid supplementation increases 1,25-dihydroxyvitamin D and fetuin-A levels in dialysis patients.
    An WS; Lee SM; Son YK; Kim SE; Kim KH; Han JY; Bae HR; Rha SH; Park Y
    Nutr Res; 2012 Jul; 32(7):495-502. PubMed ID: 22901557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?
    Lee JH; O'Keefe JH; Bell D; Hensrud DD; Holick MF
    J Am Coll Cardiol; 2008 Dec; 52(24):1949-56. PubMed ID: 19055985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.